title: Role of radiosynovectomy in the treatment of rheumatoid arthritis and hemophilic arthropathies.
abstract: Radiosynovectomy is a novel method of treatment for several acute and chronic inflammatory joint disorders. A small amount of a beta-emitting radionuclide is injected into the affected joint delivering a radiation dose of 70 to 100 Gy to the synovia. The proliferative tissue is destroyed, secretion of fluid and accumulation of inflammation causing cellular compounds stops and the joint surfaces become fibrosed, providing long term symptom relief. The radionuclides are injected in colloidal form so that they remain in the synovium and are not transported by lymphatic vessels causing radiation exposure to other organs. Complete reduction of knee joint swelling has been seen in above 40% and pain relief in 88% of patients. Wrist, elbow, shoulder, ankle and hip joints showed significant improvement in 50-60% and restoration of normal function and long term pain relief has been achieved in about 70% of small finger joints. In hemophilic arthropathies complete cessation of bleeding in about 60% and improved mobility in 75% of patients has been reported.
authors: Department of Nuclear Medicine, Radiotherapy and Oncology, School of Medical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
authors: Bk
authors: B
authors: Das
references: Nucl Med Commun. 2002 Sep;23(9):829-31
references: 12195084
references: Scand J Rheumatol. 1979;8(2):71-4
references: 377476
references: Nucl Med Biol. 2002 Jul;29(5):593-8
references: 12088730
references: Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):BP12-6
references: 12723558
references: Ann Chir Main Memb Super. 1991;10(3):243-6
references: 1718359
references: J Am Acad Orthop Surg. 2004 Jan-Feb;12(1):55-64
references: 14753798
references: Semin Nucl Med. 2001 Oct;31(4):330-41
references: 11710775
references: J Nucl Med. 2002 Nov;43(11):1489-94
references: 12411553
references: Nucl Med Biol. 2001 Aug;28(6):727-32
references: 11518655
references: Scand J Rheumatol. 1972;1(2):53-60
references: 4659182
references: Appl Radiat Isot. 2003 Apr;58(4):463-8
references: 12672625
references: Med Monatsschr Pharm. 2003 Sep;26(9):303-8
references: 14526614
references: J Am Med Assoc. 1949 Jun 25;140(8):659-62
references: 18150288
references: Presse Med. 1968 May 4;76(22):1045-50
references: 5648676
references: Ann Chir. 1974 Nov;28(10):883-9
references: 4447328
references: Nucl Med Biol. 2001 Aug;28(6):719-25
references: 11518654
references: Clin Orthop Relat Res. 2001 Nov;(392):409-17
references: 11716416
references: Arch Pharm Res. 2003 Feb;26(2):168-72
references: 12643596
references: Z Rheumatol. 1997 Jul-Aug;56(4):207-13
references: 9417761
references: Ann Rheum Dis. 1969 May;28(3):300-2
references: 5772524
references: Fortschr Med. 1982 Sep 23;100(36):1673-7
references: 7141368
references: Rheumatol Int. 2003 Sep;23(5):216-20
references: 14504912
references: Nuklearmedizin. 2001 Jun;40(3):91-7
references: 11475079
references: Nucl Med Commun. 2001 Feb;22(2):239-46
references: 11258412
references: Ann Rheum Dis. 1973 Dec;32 Suppl 6:Suppl:48-50
references: 4769195
references: Strahlenther Onkol. 1993 Jul;169(7):383-6
references: 8342110
references: Z Rheumatol. 1977 Sep-Oct;36(9-10):316-31
references: 930427